Overview

Benign prostatic hyperplasia (BPH) is reported as the fourth most common condition among older men. Lower urinary tract symptoms (LUTS) affect quality of life. The more severe the symptoms, the greater the impact on your patients’ health status. ^{1, 2}

Learn more about patient care

Discover how technology
can lead to a better
and more effective
treatment for BPH

Design that improves patient outcomes

Boston Scientific believes in providing the right treatment at the right time. From hands-on training, to patient education, we provide a wealth of resources to help ensure that your patients receive the BPH treatment which best suits them.

Learn more about other treatment methods

Clinical Evidence

Choosing the right treatment option may require a thorough conversation with your patient and an understanding of the technologies as well as the clinical evidence.

The International Prostate Symptom Score (IPSS) is an eight-question screening tool used to screen, diagnose, track the symptoms and suggest symptom management solutions for BPH. The below graphs reflect how patients who had undergone laser or water vapour therapy showed a decreased IPSS score as time progressed.

Rezūm™ water vapour thermal therapy for lower urinary tract symptoms. Results from a randomized controlled study: IPSS improvement of -10.1 points (46.7%). ³

Photoselective vaporisation of the prostate with the 180-W XPS-GreenLight™ laser: Functional outcomes over the 5-year study period (all patients) on IPSS ⁴